Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- typical skin lesions
- nerve involvement
- sensory loss
Outros fatores diagnósticos
- immunologic reactions
- eye lesions
Fatores de risco
- close contact with a person with multibacillary leprosy
- poverty
- residence in endemic area
- genetic predisposition
- zoonotic transmission
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- skin smear
- skin and/or nerve biopsy and histopathology
Investigações a serem consideradas
- polymerase chain reaction
Algoritmo de tratamento
multibacillary (MB) or paucibacillary (PB): no rifampin or fluoroquinolone resistance
multibacillary (MB) or paucibacillary (PB): rifampin ± fluoroquinolone resistance
type 1 reaction (reversal reaction)
type 2 reaction (erythema nodosum leprosum)
Lucio phenomenon
Colaboradores
Autores
Maria T. Ochoa, MD
Clinical Professor of Dermatology
USC Keck School of Medicine
Department of Dermatology
Los Angeles
CA
Declarações
MTO declares that she has no competing interests.
Agradecimentos
Dr Maria T. Ochoa would like to gratefully acknowledge Dr Denis Paul Jacques Daumerie, a previous contributor to this topic. DPJD declares that he has no competing interests.
Revisores
Hubert Sansarricq, MD
Member of World Health Organization Panel of Experts on Leprosy
Saint-Armour Morlaas
France
Declarações
HS declares that he has no competing interests.
David M. Scollard, MD, PhD
Chief
Clinical Branch
National Hansen's Disease Programs
Baton Rouge
LA
Declarações
DMS declares that he has no competing interests.
Alexandre Tiendrebéogo, MD, MPH
Medical Officer
Leprosy and Neglected Tropical Diseases in Central Africa Countries
World Health Organization
Country Office of Kinshasa
DR of Congo
Declarações
AT declares that he has no competing interests.
Referências
Principais artigos
World Health Organization. Towards zero leprosy. Global leprosy (Hansen’s Disease) strategy 2021-2030. Apr 2021 [internet publication].Texto completo
World Health Organization. Implementation of MDT. In: Multidrug therapy against leprosy: development and implementation over the past 25 years. Geneva: World Health Organization; 2004:45-68.Texto completo
World Health Organization. Guidelines for the diagnosis, treatment and prevention of leprosy. Oct 2018 [internet publication].Texto completo
World Health Organization. Leprosy/Hansen disease: management of reactions and prevention of disabilities. 2020 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Psoriasis
- Eczema
- Tinea corporis
Mais Diagnósticos diferenciaisDiretrizes
- Towards zero leprosy. Global leprosy (Hansen’s Disease) strategy 2021-2030
- Leprosy/Hansen disease: contact tracing and post-exposure prophylaxis
Mais DiretrizesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal